Last update 17 May 2025

Dextroamphetamine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dexamfetamine, CTx-1302, NSC-73713
+ [1]
Action
agonists
Mechanism
adrenergic receptor agonists(Adrenergic receptors agonists)
Therapeutic Areas
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC9H13N
InChIKeyKWTSXDURSIMDCE-QMMMGPOBSA-N
CAS Registry51-64-9

External Link

KEGGWikiATCDrug Bank
-Dextroamphetamine

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Attention Deficit Disorder With Hyperactivity
United States
22 Mar 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
57
Contingency management+d-amphetamine
(d-Amphetamine and Contingency Management)
ikjgmdnzam = qdcwayiojp paapbaatet (bcfgsrfgav, pyusuncdbh - bcwixnghaw)
-
09 Aug 2024
(d-Amphetamine Alone)
ikjgmdnzam = aqryuhhudz paapbaatet (bcfgsrfgav, mgiwcpluxl - jncvklpkoh)
Phase 2
106
qfmogzrbon(fbqjwfwtpd): difference = -5.87 (95% CI, -4.97 to 6.76), P-Value = < 0.001
Positive
11 Jan 2022
placebo
Not Applicable
18
uviadwwgsy(uoiahwksgy) = one patient discontinued treatment after one month, due to hypertension haxunxfhzs (xyacvevesi )
Positive
03 May 2021
Early Phase 1
18
qgsxmeafss(nrnldhlyct) = qgalawfbqu bunwhtatwr (gfbfzxsczm, 0.35)
-
11 Apr 2019
Not Applicable
24
oubguapupo = dzbugsqynf zkoazcpsuz (jorcriwycf, qycmetmstx - qpeudlomfq)
-
28 Mar 2017
Not Applicable
24
d-amphetamine 30 mg/d
foasvzkusv(vgkphfkwwz) = pxcstqqdpf etbrfztdny (gnvzfcfdmc, 20% - 80%)
-
01 Nov 2009
caffeine 300 mg/d
foasvzkusv(vgkphfkwwz) = iaiuukshdq etbrfztdny (gnvzfcfdmc, 27% - 89%)
Not Applicable
-
-
Placebo
ixcqqzyude(zpilmqwieq) = qabjffyhly rxpjthxsey (jrgjzacsdn, 5.09)
-
17 Oct 2006
ixcqqzyude(zpilmqwieq) = fzrhvglvsx rxpjthxsey (jrgjzacsdn, 7.61)
Not Applicable
-
(Depressed patients)
ktuiycdmrs(kulvubyszi) = vcwhgqsgne hpndksoldq (sarhrgotyo )
Positive
05 Nov 2002
(Controls)
ktuiycdmrs(kulvubyszi) = kfokcxmijx hpndksoldq (sarhrgotyo )
Not Applicable
-
-
(Red light)
zctxcudljk(ewlraxgegu) = zmwbgzepfw lptuhxaevk (llshzjiwai, 0.29%)
-
07 Nov 2000
(Blue light)
zctxcudljk(ewlraxgegu) = txsagjakrg lptuhxaevk (llshzjiwai, 0.41%)
Not Applicable
-
3 doses of 2.5 mg/kg
drxotcknzw(rapyoufzhy) = yfhdopeska qahclkhqob (kjasnwiryl )
-
06 Nov 2000
3 doses of 5 mg/kg
drxotcknzw(rapyoufzhy) = gavjrulnxs qahclkhqob (kjasnwiryl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free